🇺🇸
United States · US · US:68135-020_02482a8a-8333-4e9c-a9dc-ff7780f40363
NAGLAZYME
UNIISPLATC A16AB08
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerBioMarin Pharmaceutical Inc.
CountryUS (United States)
ATC codeA16AB08
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1168135020011 VIAL in 1 CARTON (68135-020-01) / 5 mL in 1 VIAL
Annotations
UNII (FDA Substance ID)
59UA429E5G
GALSULFASE
RxCUI 578033
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "59UA429E5G",
"rxcui": "578033",
"inchikey": null,
"display_name": "GALSULFASE",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"59341250-deac-ed71-3823-a4f5d64dbd77": {
"match": "brand_token",
"title": "NAGLAZYME (GALSULFASE) SOLUTION [BIOMARIN PHARMACEUTICAL INC.]",
"spl_version": "39",
"published_date": "2024-12-12"
}
},
"productid": "68135-020_02482a8a-8333-4e9c-a9dc-ff7780f40363",
"productndc": "68135-020",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "GALSULFASE",
"proprietary_name": "NAGLAZYME",
"active_ingred_unit": "mg/5mL",
"application_number": "BLA125117",
"marketing_category": "BLA",
"nonproprietary_name": "galsulfase",
"start_marketing_date": "20050609",
"active_numerator_strength": "5"
}Related drugs
Other records sharing ATC code A16AB08.
- ISNaglazymeBioMarin International Limited
- FINaglazymeBiomarin International Limited
- PLNaglazymeBioMarin International Ltd.
- 🇨🇭NaglazymeDRAC AG
- DKNaglazymeBioMarin International Limited
- NONaglazymeBioMarin International Limited
- CZNAGLAZYMEBioMarin International Limited, Dublin
- CZNAGLAZYMEBioMarin International Limited, Dublin
Access this data programmatically
Query NAGLAZYME and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.